INDIGO Biosciences Launches CHRM1 (Cholinergic Receptor, Muscarinic 1) Reporter Assays for Cognitive Drug Discovery
New Assay Expands INDIGO’s GPCR Portfolio and Supports Development of Next-Generation CNS-Related Therapeutics STATE COLLEGE, PA, UNITED STATES, March 19, 2026 /EINPresswire.com/ -- INDIGO Biosciences, a leading provider of cell-based reporter …